|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,959.50 GBX | -1.01% |
|
+1.53% | +7.40% |
| 07-10 | Gsk plc Announces Appointment of Roy Jakobs to Non-Executive Director, Effective July 13, 2026 | CI |
| 07-09 | Wall Street Ignores the Sirens |  |
| Market Cap | 78.08B 105B 91.56B 84.46B 148B 9,987B 151B 1,011B 396B 4,917B 393B 385B 17,002B | P/E 2026 * |
12.5x | P/E 2027 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 93.37B 125B 109B 101B 177B 11,943B 180B 1,210B 474B 5,880B 470B 460B 20,332B | EV / Sales 2026 * |
2.76x | EV / Sales 2027 * | 2.54x |
| Free-Float |
92.29% | Yield 2026 * |
3.56% | Yield 2027 * | 3.74% |
Last Transcript: GSK plc
| 1 day | -1.01% | ||
| 1 week | +1.53% | ||
| Current month | -1.09% | ||
| 1 month | +2.43% | ||
| 3 months | -7.79% | ||
| 6 months | +3.62% | ||
| Current year | +7.40% |
| 1 week | 1,951 |  | 2,049 |
| 1 month | 1,890.5 | | 2,049 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 06-08 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 05-22 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +1.53% | +38.58% | +48.90% | 105B | |
| +0.09% | +2.12% | +56.49% | +169.19% | 1,084B | |
| -1.63% | +2.02% | +66.31% | +62.70% | 634B | |
| -1.12% | -0.46% | +31.69% | +84.44% | 447B | |
| +0.18% | +2.04% | +30.19% | +26.51% | 330B | |
| -6.22% | -3.61% | +29.15% | +32.09% | 295B | |
| -1.27% | -0.56% | +27.21% | +46.39% | 285B | |
| -0.93% | -1.19% | -28.85% | -40.38% | 218B | |
| -1.19% | +0.63% | +22.43% | +66.30% | 199B | |
| -0.72% | +7.04% | +21.41% | +81.19% | 169B | |
| Average | -1.02% | +2.52% | +29.46% | +57.73% | 376.53B | |
| Weighted average by Cap. | -0.51% | +2.48% | +39.73% | +83.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.86B 45.42B 39.71B 36.63B 64.35B 4,331B 65.42B 439B 172B 2,133B 170B 167B 7,374B | 35.59B 47.73B 41.73B 38.5B 67.63B 4,552B 68.75B 461B 181B 2,242B 179B 175B 7,750B |
| Net income | 6.5B 8.72B 7.63B 7.04B 12.36B 832B 12.57B 84.27B 33B 410B 32.72B 32.04B 1,416B | 7.04B 9.44B 8.25B 7.61B 13.37B 900B 13.59B 91.16B 35.7B 443B 35.4B 34.66B 1,532B |
| Net Debt | 15.29B 20.51B 17.93B 16.54B 29.06B 1,956B 29.54B 198B 77.59B 963B 76.92B 75.32B 3,330B | 12.23B 16.41B 14.34B 13.23B 23.24B 1,565B 23.63B 158B 62.06B 770B 61.53B 60.25B 2,664B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | GBX 1,959.50 | -1.01% | 5,592,972 |
| 08/07/26 | GBX 1,979.50 | -1.17% | 4,243,789 |
| 07/07/26 | GBX 2,003.00 | +1.01% | 4,183,855 |
| 06/07/26 | GBX 1,983.00 | -1.59% | 15,158,597 |
| 03/07/26 | GBX 2,015.00 | +0.55% | 2,548,759 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
